LEXINGTON, Mass., Aug. 2, 2018 /PRNewswire/ -- Aldeyra
Therapeutics, Inc. (NASDAQ:ALDX) (Aldeyra), a biotechnology company
devoted to development of next-generation medicines to improve the
lives of patients with immune-mediated diseases, will hold a
conference call on Thursday, August 9,
2018, at 8:00 a.m. EDT to
discuss financial results for the quarter ended June 30, 2018 and provide a corporate
update. The dial-in numbers are 1-877-266-8979 for domestic
callers and 1-412-317-5231 for international callers. A live
webcast of the conference call will also be available on the
investor relations page of the Aldeyra Therapeutics corporate
website at www.aldeyra.com.
After the live webcast, the event will remain archived on the
Aldeyra Therapeutics website for one year.
About Aldeyra
Therapeutics
Aldeyra Therapeutics is
developing next-generation medicines to improve the lives of
patients with immune-mediated diseases. Aldeyra's lead product
candidate, reproxalap, is a first-in-class treatment in late-stage
development for dry eye disease and other forms of ocular
inflammation. The company is also developing other product
candidates for autoimmune and metabolic diseases. None of Aldeyra's
product candidates have been approved for sale in the U.S. or
elsewhere.
Corporate Contact:
David McMullin
Aldeyra Therapeutics, Inc.
Tel: 781-761-4904 ext. 218
dmcmullin@aldeyra.com
Investor Contact:
Chris Brinzey
Westwicke Partners
Tel: 339-970-2843
Chris.brinzey@westwicke.com
Media Contact:
Cammy Duong
MacDougall Biomedical Communications
781-591-3443
cduong@macbiocom.com
View original
content:http://www.prnewswire.com/news-releases/aldeyra-therapeutics-schedules-webcast-and-conference-call-to-provide-second-quarter-2018-financial-results-and-corporate-update-300690941.html
SOURCE Aldeyra Therapeutics, Inc.